Blake Bolinger
About Blake Bolinger
Blake Bolinger is the Director of Compliance at Bristol-Myers Squibb with over 25 years of experience in pharmaceutical sales and marketing compliance.
Current Title and Role
Blake Bolinger serves as the Director of Compliance at Bristol-Myers Squibb. In this role, he oversees compliance training and ensures adherence to regulatory standards during global product commercialization. His responsibilities include managing compliance protocols and supporting the company's commitment to ethical practices.
Education Background
Blake Bolinger earned his Juris Doctor (JD) degree from Rutgers Law School, where he studied from 1988 to 1991. Prior to that, he attended the University of Washington and earned a Bachelor's Degree, studying from 1985 to 1987. His educational journey began at Radford High School, where he completed his studies from 1981 to 1983.
Experience in Pharmaceutical Compliance
Blake Bolinger has amassed over 25 years of experience in pharmaceutical sales and marketing compliance. His extensive background in the industry includes a specialization in FDA regulatory law. He is well-versed in navigating the complexities of compliance within the pharmaceutical sector, bringing invaluable expertise to his current role at Bristol-Myers Squibb.
Specialization in FDA Regulatory Law
Blake Bolinger specializes in FDA regulatory law, ensuring that pharmaceutical products meet the stringent standards set by the Food and Drug Administration. His expertise in this area is crucial for maintaining compliance and preventing legal issues related to product commercialization and marketing practices.
Expertise in Managed Markets and Medical Affairs
Blake Bolinger's expertise extends to managed markets and medical affairs. His role involves understanding and navigating the intricacies of these fields to ensure that Bristol-Myers Squibb's products are compliant with relevant regulations and standards. This knowledge is essential for the company's interactions with healthcare providers and payers.